Efficacy of low-dose aspirin in preventing hypertensive disorders of pregnancy in women with systemic lupus erythematosus: A single-center retrospective cohort study
Modern Rheumatology · 2026
DOI: 10.1093/mr/roag028 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Modern Rheumatology, 2026. Verfasst von Chie Kohno und 8 weiteren Autor:innen. Beteiligte Einrichtung: Japan Drug Information Institute in Pregnancy, Integrated Center for Women's Health, National Center for Child Health and Development, Tokyo, Japan. Hauptthemen laut MEDLINE: Aspirin, Lupus Erythematosus, Systemic, Hypertension, Pregnancy-Induced, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: AMED.
Abstract (Originalsprache)
Objectives
Low-dose aspirin (LDA) is widely recommended to prevent hypertensive disorders of pregnancy (HDP). However, the evidence of its effectiveness in pregnancies with systemic lupus erythematosus (SLE) remains limited. This study evaluated the efficacy of LDA in preventing HDP in women with SLE.
Methods
We conducted a retrospective cohort study of 124 pregnancies with SLE managed at our hospital. Pregnancy outcomes were compared between women treated with LDA and those not treated, using propensity score and inverse probability weighting analyses to adjust for confounders.
Results
LDA was used in 65 pregnancies and not used in 59. HDP occurred in 7/65 (10.8%) and 8/59 (13.6%), respectively. After adjusting for potential confounders, including antiphospholipid antibodies, lupus nephritis, chronic hypertension, chronic kidney disease, history of HDP, and hydroxychloroquine use, the risk ratio for HDP with LDA was 0.76 (95% confidence interval: 0.25–2.33; P = .64). Sensitivity analysis was consistent.
Conclusions
LDA did not significantly reduce the incidence of HDP in women with SLE. This lack of effect may reflect the low event rate in a well-controlled cohort. These findings underscore the need for individualized risk assessment and careful monitoring, beyond reliance on LDA alone, in the management of pregnancies with SLE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Japan Drug Information Institute in Pregnancy, Integrated Center for Women's Health, National Center for Child Health and Development, Tokyo, Japan.
- Division of Maternal Medicine, Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan.
- The Institute of Statistical Mathematics, Tokyo, Japan.
- Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Iruma, Saitama, Japan.
ORCID-Profile: Chie Kohno, Akitsu Higuchi, Shuko Mishima, Kayoko Kaneko
Förderung
- AMED
Zitieren
APA
Kohno, C., Higuchi, A., Miyagawa, E., Mishima, S., Abe, S., Takai, C., Noma, H., Murashima, A., & Kaneko, K. (2026). Efficacy of low-dose aspirin in preventing hypertensive disorders of pregnancy in women with systemic lupus erythematosus: A single-center retrospective cohort study. Modern Rheumatology. https://doi.org/10.1093/mr/roag028
Vancouver
Kohno C, Higuchi A, Miyagawa E, Mishima S, Abe S, Takai C, et al. Efficacy of low-dose aspirin in preventing hypertensive disorders of pregnancy in women with systemic lupus erythematosus: A single-center retrospective cohort study. Modern Rheumatology. 2026. doi:10.1093/mr/roag028
BibTeX
@article{Kohno2026,
author = {Kohno, Chie and Higuchi, Akitsu and Miyagawa, Eiko and Mishima, Shuko and Abe, Sawako and Takai, Chinatsu and Noma, Hisashi and Murashima, Atsuko and Kaneko, Kayoko},
title = {Efficacy of low-dose aspirin in preventing hypertensive disorders of pregnancy in women with systemic lupus erythematosus: A single-center retrospective cohort study},
journal = {Modern Rheumatology},
year = {2026},
doi = {10.1093/mr/roag028}
}
EUVIMED